The benefit of adjuvant chemotherapy in pathological T1–3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data
Our study found that RM is a poor prognostic factor in pathological T1-3N0M0 RC. However, AT does not appear necessary to improve survival outcomes of pathological T1-3N0M0 RM.
Authors
- Hualin Liao
- Dongsheng Li (ORCID: https://orcid.org/0000-0002-1578-1239)
- Hongliang Zhu (ORCID: https://orcid.org/0009-0005-8204-3411)
- Jiyang Li (ORCID: https://orcid.org/0000-0003-3731-6714)
- Tengyu Zeng
- Fan Chen (ORCID: https://orcid.org/0000-0002-0530-9248)
- Kejin Yan
- Xianqiang Xie
Institutions
- People's Liberation Army 401 Hospital (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/jgo-24-271
- Citations
- 2
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 1.15